Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Phase 2 pancreatic cancer study is displayed, including its treatment arms, eligibility criteria, outcome measure, and study history.
    Difference
    40%
    Check dated 2026-11-09T14:57:51.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:35:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:46:58.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-19T20:46:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T04:12:13.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the expected study details and navigation. This indicates the page is currently inaccessible due to access restrictions or server configuration.
    Difference
    17%
    Check dated 2026-09-21T22:21:01.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.